Jill Elliott

Jill Elliott has extensive experience in the pharmaceutical industry, with a particular focus on marketing and commercialization. Jill is currently the Vice President and Head of Marketing at X4 Pharmaceuticals since June 2023. Prior to this, they served as the Vice President of Cell Therapy Commercialization at Novo Nordisk from April 2021 to February 2023. Jill also has experience at bluebird bio, where they held various leadership roles including Vice President of Global Marketing and Global Commercial Lead for gene therapy programs. Before that, they worked at Vertex Pharmaceuticals as a Senior Director in global marketing and commercial excellence. Jill began their career at EMD Serono, Inc. as a Marketing Director and launch lead for neurology products. Jill also gained consulting experience at The Boston Consulting Group as a Manager in the healthcare practice. Jill's work experience spans over 20 years and they have demonstrated expertise in driving marketing strategies and commercialization efforts in the pharmaceutical industry.

Jill Elliott holds an MBA from The Tuck School of Business at Dartmouth and a BS from Boston College.